MedicaidPrior AuthLow impact
MAB2022071102
Pennsylvania Medicaid (DHS)·PA · Neurology, Family Medicine, Internal Medicine +2 more·Provider Bulletin
Effective date
Sep 1, 2022
We identified it
Jun 20, 2026
Summary
Pennsylvania Medical Assistance updated prior authorization guidelines for Antiparkinson's Agents, clarifying language but making no substantive changes to medical necessity requirements. Non-preferred drugs and quantities exceeding limits still require prior authorization.
Action Required
No immediate action required. This is a clarification of existing Pennsylvania Medicaid prior authorization requirements for Antiparkinson's Agents with no substantive changes to guidelines. Billing team should continue following current prior authorization procedures for non-preferred Antiparkinson's Agents and quantities exceeding limits.